ORMP News and Press, Oramed Pharmaceuticals Inc. From 08/06/21

Sphere 3D Corp (NASDAQ:ANY) +43% agreement to acquire exclusive rights for assignment of cryptocurrency mining assets Kaixin Auto (NASDAQ:KXIN) +23% on foraying into new energy vehicle business Switch (NYSE:SWCH) +19% on Q2 earnings Westport Fuel (NASDAQ:WPRT) +1...

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) traded today at a new 52-week high of $17.68. So far today approximately 251,000 shares have been exchanged, as compared to an average 30-day volume of 703,000 shares. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) is currently priced 27.4% above its ...

Oravax to Present Keynote Talk on Oral COVID-19 Vaccine at the Arena International Vaccines Virtual Conference 2021 Keynote Talk: Development of the World's First Triple Antigen Oral SARS Cov-2 Vaccine PR Newswire NEW YORK , Aug. 5, 2021 /PRNewswire/ -- Orame...

Oramed Pharmaceuticals (NASDAQ:ORMP) appoints Michael Rabinowitz to the newly created position of chief commercial officer effective August 1, 2021. Mr. Rabinowitz will be responsible for Oramed's overall commercial strategy and execution. Mr. Rabinowitz is a highly a...

Oramed Pharmaceuticals Appoints Chief Commercial Officer PR Newswire NEW YORK , July 29, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of ora...

Penny stocks are just one of the hot trends in the stock market this week. Biotech has now become one of the sectors to follow this month. If you look at the Nasdaq Biotech ETF ( NASDAQ:IBB ), you’ll see what I mean. Kicking off the July 26th session, it hit a fresh 4-month high....

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) traded today at a new 52-week high of $16.63. So far today approximately 245,000 shares have been exchanged, as compared to an average 30-day volume of 573,000 shares. Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the...

ACELYA AKSUNKUR/iStock via Getty Images Announcing updates of its majority-owned company Oravax Medical, Oramed Pharmaceuticals (ORMP) said clinical trials for the unit’s oral COVID-19 vaccine would get underway first in Israel and then in additional sites globally. The study prot...

Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial - Oravax's virus-like particle (VLP) vaccine being tested against COVID-19 variants including Delta - Oravax signs licensing deal for VLP injectable vaccine technology with Premas Biote...

A clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, Oramed Pharmaceuticals (ORMP) set to join the U.S. small cap Russell 2000 and broad-market Russell 3000 Index at annual reconstitution, effective June 28, 2021.Membership in the&#x...